This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Kajubi,¹ in his letter to the editor, which was published in the February 14, 2000, issue of the ARCHIVES, makes a good case for the use of aspirin in type 2 diabetes mellitus, "in the absence of contraindications." Many patients with chronic diabetes have diabetic retinopathy and neovascularization and are prone to fundal bleeding. When should aspirin be contraindicated in a patient with diabetic retinopathy?

H. T. Ong, MBBS(Mal), FRCP(Glasg/Edin)
Penang, Malaysia

1. Kajubi SK. Aspirin in the treatment of type 2 diabetes. Arch Intern Med. 2000;160:394. FREE FULL TEXT

In reply

I am happy to respond to Dr Ong's question, which was prompted by my letter on aspirin in the treatment of type 2 diabetes.¹ The treatment of diabetic retinopathy in general was recently reviewed,² and the place of aspirin in this context has been addressed by at least 2 studies^3-4 that showed that aspirin did not affect the progression of retinopathy, the risk of visual loss,³ or the risk of vitreous hemorrhage among patients with proliferative . . . [Full Text of this Article]

RELATED ARTICLE

Aspirin in the Treatment of Type 2 Diabetes
Samuel K. Kajubi
Arch Intern Med. 2000;160(3):394.
EXTRACT | FULL TEXT